2020年新冠疫情期间美国医保受益人常规疫苗接种量下降
研究基于美国医保A、B、D部分参保与理赔数据,比较2020年1月5日至7月18日与2019年同期65岁及以上受益人四种常规疫苗的每周接种率。国家紧急状态声明后,四种疫苗每周接种率较2019年同期最多下降89%,所有种族和族裔群体均下降,至7月中旬仍未完全恢复(PPSV23除外)。
要点
- 2020年3月中旬国家紧急状态声明后,四种常规疫苗每周接种率较2019年同期最多下降89%。
- 紧急状态声明后第一周,每周接种率较2019年对应周低25%–62%。
- 2020年4月第二至第三周接种率降至最低(较2019年低70%–89%),至7月中旬仍未恢复至2019年水平(PPSV23除外)。
核心结论
- 新冠疫情期间美国65岁及以上医保受益人四种常规成人疫苗每周接种率大幅下降,所有种族和族裔群体均受影响,至2020年7月中旬多数疫苗仍未恢复至2019年水平。
研究设计与样本
- 基于美国医保A、B、D部分参保与理赔数据,比较2020年1月5日至7月18日与2019年1月6日至7月20日65岁及以上受益人四种疫苗的每周接种率,并按种族和族裔分层分析。
主要发现
- 国家紧急状态声明后,四种疫苗每周接种率较2019年同期最多下降89%。
- 紧急状态声明后第一周,每周接种率较2019年对应周低25%–62%。
- 2020年4月第二至第三周接种率降至最低,较2019年低70%–89%,此后逐渐恢复。
- 至研究最后一周,除PPSV23外,其余疫苗每周接种率仍低于2019年同期。
- 所有受检疫苗及所有种族和族裔群体的接种率均大幅下降。
临床怎么用
- 疫情期间疫苗接种提供者应向患者强调继续接种常规疫苗的重要性,并解释已采取的患者安全措施以消除顾虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On March 13, 2020, the United States declared a national emergency concerning the novel coronavirus disease 2019 (COVID-19) outbreak (1). In response, many state and local governments issued shelter-in-place or stay-at-home orders, restricting nonessential activities outside residents' homes (2). CDC initially issued guidance recommending postponing routine adult vaccinations, which was later revised to recommend continuing to administer routine adult vaccines (3). In addition, factors such as disrupted operations of health care facilities and safety concerns regarding exposure to SARS-CoV-2, the virus that causes COVID-19, resulted in delay or avoidance of routine medical care (4), likely further affecting delivery of routine adult vaccinations. Medicare enrollment and claims data of Parts A (hospital insurance), B (medical insurance), and D (prescription drug insurance) were examined to assess the change in receipt of routine adult vaccines during the pandemic. Weekly receipt of four vaccines (13-valent pneumococcal conjugate vaccine [PCV13], 23-valent pneumococcal polysaccharide vaccine [PPSV23], tetanus-diphtheria or tetanus-diphtheria-acellular pertussis vaccine [Td/Tdap], and recombinant zoster vaccine [RZV]) by Medicare beneficiaries aged ≥65 years during January 5-July 18, 2020, was compared with that during January 6-July 20, 2019, for the total study sample and by race and ethnicity. Overall, weekly administration rates of the four examined vaccines declined by up to 89% after the national emergency declaration in mid-March (1) compared with those during the corresponding period in 2019. During the first week following the national emergency declaration, the weekly vaccination rates were 25%-62% lower than those during the corresponding week in 2019. After reaching their nadirs of 70%-89% below 2019 rates in the second to third week of April 2020, weekly vaccination rates gradually began to recover through mid-July, but by the last study week were still lower than were those during the corresponding period in 2019, with the exception of PPSV23. Vaccination declined sharply for all vaccines studied, overall and across all racial and ethnic groups. While the pandemic continues, vaccination providers should emphasize to patients the importance of continuing to receive routine vaccinations and provide reassurance by explaining the procedures in place to ensure patient safety (3).
引用
- Hong K, Zhou F, Tsai Y, et al. Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33600384. doi:10.15585/mmwr.mm7007a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。